UnitedHealth Group Incorporated (NYSE:UNH) is Nisa Investment Advisors LLC’s fifth largest position.

Financial Advisors

Nisa Investment Advisors LLC reduced its stake in UnitedHealth Group Incorporated (NYSE: UNH – Get Rating) by 2.6% in the fourth quarter, according to its latest Securities and Exchange Commission filings. The company owned his 306,011 stake in the healthcare conglomerate after selling his 8,147 shares during the quarter. UnitedHealth Group accounts for approximately 1.3% of Nisa Investment Advisors LLC’s investment portfolio, making the company’s stock his fifth largest. Nisa Investment Advisors LLC’s stake in UnitedHealth Group was valued at $162,241,000 as of the latest SEC filing.

Other hedge funds have also changed their stakes in the company. Arcus Capital Partners LLC increased his UnitedHealth Group stake by 40.1% in the third quarter. Arcus Capital Partners LLC now owns 2,456 shares of the healthcare conglomerate worth $1,241,000 after acquiring an additional 703 shares during this period. Mitchell Capital Management Co. raised his UnitedHealth Group stake by 0.7% in the third quarter. Mitchell Capital Management Co. now owns 11,869 shares of the healthcare conglomerate worth $5,994,000 after purchasing an additional 78 shares during the period. Regent Investment Management LLC increased its stake in UnitedHealth Group by 0.5% in the third quarter. Regent Investment Management LLC now owns 9,222 shares of the healthcare conglomerate worth $4,657,000 after purchasing an additional 45 shares during this period. Beaumont Financial Advisors LLC purchased a new position in UnitedHealth Group shares in the fourth quarter for approximately $2,299,000. Finally, Railway Pension Investments Ltd increased its stake in UnitedHealth Group shares by 1.4% in the fourth quarter. Railway Pension Investments Ltd owns 426,020 shares in the healthcare conglomerate valued at $225,867,000 after purchasing a further 5,800 shares during this period. 86.31% of the shares are currently owned by hedge funds and other institutional investors.

UnitedHealth Group trading down 0.1%

UnitedHealth Group shares fell $0.55 to $504.80 in Tuesday’s trading. The company’s stock had a trading volume of 1,526,997 shares, with an average trading volume of 3,598,357 shares for him. The stock has a market capitalization of $470.9 billion, a price/earnings ratio of 23.11, a P/E/G ratio of 1.44 and a beta of 0.67. The stock has a 50-day moving average of $485.46 and a 200-day moving average of $507.06. UnitedHealth Group Incorporated hit a one-year low of $449.70 and a one-year high of $558.10. The company has an equity ratio of 0.71, a quick ratio of 0.77 and a current ratio of 0.81.

UnitedHealth Group (NYSE:UNH – Get Rating) announced final results on Friday, April 14. The healthcare conglomerate reported EPS of $6.26 for the quarter, beating the consensus estimate of $6.24 by $0.02. The company’s revenue for the quarter was $91.93 billion, compared with analyst estimates of $89.77 billion. UnitedHealth Group’s return on equity was 27.05% and net profit margin was 6.16%. Business quarterly revenue increased by 14.7% compared to the same period last year. His earnings per share for the company in the same period last year were $5.49. As a group, equity research analysts expect UnitedHealth Group Incorporated to post 24.87 EPS this year.

UnitedHealth Group Dividend Notice

The company recently announced a quarterly dividend, which was paid out on Tuesday, March 21st. Shareholders of record on Monday, March 13 were awarded a dividend of $1.65. This represents his $6.60 dividend and his 1.31% dividend yield on an annualized basis. The ex-dividend date was Friday, March 10. UnitedHealth Group payout percentage is 30.18%.

Wall Street Analyst Predicts Growth

Several equity analysts recently published reports on the company. In his Tuesday, Feb. 28 research notes, Stephens reiterated his “overweight” rating and set his UnitedHealth Group stock price target at $605.00. Loop Capital raised its price target on UnitedHealth Group to $600.00 from his $590.00, giving it a “buy” rating in its research report on Monday. StockNews.com raised its rating on UnitedHealth Group from “buy” to “strong buy” in a research report on Monday. The Royal Bank of Canada reissued an ‘outperform’ rating and set a price target of $592.00 on UnitedHealth Group shares in a research report on Monday. Finally, UBS Group lowered his UnitedHealth Group price target from $590.00 to $550.00, giving the stock a “Neutral” rating in its research report on Wednesday, January 18. Three investment analysts gave the stock a Hold rating, 12 assigned a Buy rating, and two assigned a Strong Buy rating. According to MarketBeat, the stock has an average rating of “moderate buy” and a consensus price target of $600.89.

UnitedHealth Group Company Profile

(get rating)

UnitedHealth Group, Inc provides medical insurance, software, and data consulting services. It operates through the UnitedHealthcare, OptumHealth, OptumInsight and OptumRx segments. The UnitedHealthcare segment leverages Optum’s capabilities to coordinate patient care, improve healthcare affordability, analyze cost trends, manage pharmacy benefits, work more effectively with healthcare providers, and simplify We help create the perfect consumer experience.

Recommended story

UnitedHealth Group (NYSE:UNH) Quarterly Institutional Ownership

This instant news alert was generated by Narrative Science Technology and MarketBeat financial data to provide our readers with the fastest and most accurate reporting. This article was reviewed by MarketBeat’s editorial team prior to publication. Send any questions or comments about this story to contact@marketbeat.com.

Listen to this before you consider UnitedHealth Group.

MarketBeat tracks Wall Street’s most acclaimed and top performing research analysts and the stocks they recommend to clients every day. MarketBeat has identified five stocks top analysts are quietly whispering to clients to buy now before the broader market catches on…and UnitedHealth Group is not on the list. bottom.

UnitedHealth Group is currently rated as a “moderate buy” among analysts, but top-ranked analysts believe these five stocks are better buys.

See 5 stocks here

A Beginner's Guide to Retirement Stock Covers

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *